← All stocks

PERRIGO Co plc

PRGO Net buying
CIK 0001585364 #2077 in the set updated 17 Sep 2026
Bought (120 mo)
$39.04M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.54M
$497.50K on a plan · $132.78K straight out of an exercise
Sold at will
$12.91M
48 of 50 sales
Net
+$25.50M
+$26.13M against sales at will

By person

47 insiders · 419 transactions
1.4×

Patrick Lockwood-Taylor holds only 1.4 times base salary in stock. $1.75M of shares against $1.22M in salary for 2025.

Salary from the company's own proxy. The shares are what Patrick Lockwood-Taylor last reported holding, valued at $14.18, the price Ordinary Shares was last bought or sold at on the open market here, on 12 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Smith Jeffrey C
Director
$30.18M (18)
+$30.18M
10,046,234
$142.46M
+4.2%
KESSLER MURRAY S
CEO
$1.00M (2)
$7.07M (1)
−$6.07M
2,668
$37.83K
Parker Geoffrey M.
Director
$1.53M (9)
+$1.53M
94,502
$1.34M
+439.2%
Farrington Thomas
EVP and CIO
$1.47M (13)
−$1.47M
12,908
$183.04K
+50.9%
Janish Ronald Craig
EVP, Gbl Ops & SC & CTO
$1.30M (10)
−$1.30M
40,131
$569.06K
+240.3%
SILCOCK RAYMOND
EVP, Chief Financial Officer
$990.93K (1)
+$990.93K
59,488
$843.54K
Samuels Theodore R. II
Director
$712.91K (4)
+$712.91K
44,811
$635.42K
+1,524%
Lockwood-Taylor Patrick
Former CEO and director
$670.80K (5)
+$670.80K
123,170
$1.75M
Roehrhoff Uwe
CEO
$613.86K (2)
+$613.86K
7,500
$106.35K
Brown Judy L
EVP, Business Ops & CFO
$579.52K (3)
−$579.52K
10,007
$141.90K
−38.6%
KINDLER JEFFREY B
Director
$497.50K (1) scheduled
−$497.50K
10,559
$149.73K
Alford Bradley A
Director
$479.41K (1)
+$479.41K
46,121
$654.00K
+1,464,994%
Willis Robert
EVP & CHRO
$372.94K (4)
+$372.94K
50,568
$717.05K
+19,967%
Sorota Richard S
EVP & President CSCA
$326.67K (1)
+$326.67K
11,161
$158.26K
Needham Jeffrey
EVP, President CHC Americas
$321.71K (2)
−$321.71K
31,191
$442.29K
+186.1%
Dillard James E III
EVP & President CSCA
$321.31K (1)
−$321.31K
25,130
$356.34K
Doyle Katherine C.
Director
$244.44K (1)
−$244.44K
6,009
$85.21K
Bezerra Eduardo Guarita
EVP & Chief Financial Officer
$214.09K (2)
+$214.09K
84,700
$1.20M
CLASSON ROLF A
Director
$199.77K (2)
+$199.77K
17,442
$247.33K
Andersen Svend
EVP & President CHCI
$1.16M (7)
$968.56K (3)
+$187.39K
90,581
$1.28M
+1,378%
Quinn Grainne
EVP, Chief Medical Officer
$175.56K (2)
−$175.56K
21,078
$298.89K
+913.9%
Ives Alison
EVP & Chief Scientific Officer
$168.58K (3)
+$168.58K
18,451
$261.64K
+335.8%
Kochan Sharon
EVP & President Rx
$144.42K (3)
−$144.42K
35,141
$498.30K
+489.3%
Winowiecki Ronald
CFO
$39.67K (1)
−$39.67K
7,152
$101.42K
+416.8%
Lennox Abigail
EVP and CSO
$28.12K (1)
+$28.12K
4,607
$65.33K
Wesolowski John
EVP, President Rx
$60.06K (1)
$87.84K (5)
−$27.78K
2,631
$37.31K
+237.0%
Atkinson Charles
EVP, General Counsel & Sec.
$23.20K (1)
+$23.20K
5,855
$83.02K
KINGMA TODD W
Executive VP, General Counsel
$317.42K (2)
$325.58K (4)
−$8.17K
47,269
$670.27K
JANDERNOA MICHAEL J
Director
687,617
$9.75M
+56.8%
O'Connor Donal
Director
35,633
$505.28K
+1,168%
ASHFORD ORLANDO D
Director
27,717
$393.03K
Karaboutis Adriana
Director
27,629
$391.78K
COHEN GARY M
Director
20,317
$288.10K
+52.2%
HENDRICKSON JOHN T
CEO
18,321
$259.79K
+24.0%
Mann Erica L
Director
17,458
$247.55K
Manzone Albert
Interim President and CEO
16,353
$231.89K
BRLAS LAURIE
Director
15,329
$217.37K
+46.6%
Khoury Roberto
EVP and President of CSCI
14,113
$200.12K
Brown Julia M
Director
11,832
$167.78K
Ball David
EVP & CBDO
11,664
$165.40K
HANSON KYLE
EVP & General Counsel
11,137
$157.92K
Winterman Matthew John
EVP, Supply, Ops, Strategy
8,365
$118.62K
Schmelter Triona
EVP & President CSCA
6,670
$94.58K
Samuelson Jonas
Director
5,392
$76.46K
+1,854%
Weninger Paul
EVP, Quality Operations
5,392
$76.45K
+45.5%
Egan Kevin Francis
Director
3,798
$53.86K
Michaud James R
EVP, Chief HR Officer
0
$0.00

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Janish Ronald Craig
10 Mar 2025
EVP, Gbl Ops & SC & CTO
Sell
7,800
$27.44
$214.03K
Doyle Katherine C.
13 Sep 2024
Director
Sell
8,954
$27.30
$244.44K
Janish Ronald Craig
26 Aug 2024
EVP, Gbl Ops & SC & CTO
Sell
13,000
$29.40
$382.25K
Andersen Svend
20 Aug 2024
EVP & President CHCI
Sell indirect
6,683
$27.43
$183.28K
Andersen Svend
20 Aug 2024
EVP & President CHCI
Sell
7,800
$27.46
$214.15K
Andersen Svend
20 Aug 2024
EVP & President CHCI
Sell
20,500
$27.86
$571.13K
KESSLER MURRAY S
11 May 2023
CEO
Sell
197,646
$35.75
$7.07M
Farrington Thomas
13 Mar 2023
EVP and CIO
Sell
200
$35.59
$7.12K
Farrington Thomas
13 Mar 2023
EVP and CIO
Sell
3,523
$35.57
$125.32K
Dillard James E III
10 Mar 2023
EVP & President CSCA
Sell
9,000
$35.70
$321.31K
Janish Ronald Craig
8 Mar 2023
EVP, Gbl Ops & SC & CTO
Sell
4,500
$36.92
$166.13K
Quinn Grainne
16 Dec 2022
EVP, Chief Medical Officer
Sell
2,368
$31.65
$74.95K
Farrington Thomas
14 Mar 2022
EVP and CIO
Sell indirect
2,259
$37.23
$84.10K
Farrington Thomas
14 Mar 2022
EVP and CIO
Sell
24,485
$37.13
$909.08K
Janish Ronald Craig
7 Mar 2022
EVP, Gbl Ops & SC & CTO
Sell
3,954
$36.73
$145.23K
Janish Ronald Craig
10 Mar 2021
EVP, Gbl Ops & SC & CTO
Sell
2,662
$41.23
$109.77K
Showing 250 of 419 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 510
Amendments (4/A) skipped 19
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 3,029,112
Sales filed before the plan box existed 41
History held since 9 Sep 2016